FDA recalls levothyroxine sodium tablets. Here's what to know

FDA因生产质量问题，关闭了大量用于治疗甲状腺功能减退症的药片，从而导致该领域患者面临着重大健康挑战。回收药品的原因是该药品由于生产不均性而发生了降低活性的问题，这种情况也被称为“亚表效药”状态。 美联社 recently announce that the United States Food and Drug Administration (FDA) recalled a type of medication commonly used to treat thyroid problems. The recall affects Levothyroxine sodium tablets, which are widely used to regulate thyroid hormone levels and treat hypothyroidism.

According to official statement, the FDA claim that the pharmaceutical company Major Pharmaceuticals and distribution company Cardinal Health have delivered tablets with less active ingredients than expected. Levothyroxine sodium tablets were widely distributed across the country, although specific number not specified.

The recalled drugs belong to a category known as Class II drugs, which can cause temporary adverse reactions or less serious but persistent effects. Users of these medications can monitor for signs of illness such as dizziness or palpitations.

AI 创作日志: 本文由 llama3.2:latest 独立创作，仅供参考。

• recall thyroid medicine
• llama3.2:latest